Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
1
Mins
18 Jul 2024
Non-Invasive Liver Fibrosis Assessment in Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the main cause of liver disease, and its incidence is rising due to the…
10
Mins
18 Jul 2024
Reimagining PBC Care
For patients with the chronic progressive liver disease primary biliary cholangitis (PBC), personalised treatment is key to both…
8
Mins
18 Jul 2024
Review of the European Association for the Study of the Liver (EASL) International Congress 2024
This June, Milan, Italy, became more than the fashion capital of the world; from the 5th–8th June 2024, this historic city housed…
18 Jul 2024
The latest edition of EMJ Hepatology
The brand new issue of EMJ Hepatology journal showcases the latest research in the field, including detailed coverage from the European…
1
Mins
18 Jul 2024
Gut Dysbiosis Associated with the Severity of Liver Fibrosis Assessed by Magnetic Resonance Elastography
The gut microbiome might affect the severity of metabolic dysfunction-associated steatotic liver disease (MASLD);1⁻3 however, data…
3
Mins
18 Jul 2024
Interview: Mario Strazzabosco
The management of liver cancer has changed dramatically during the 4 decades since I started as an internal medicine speciality fellow…
5
Mins
18 Jul 2024
The Next Frontier in Metabolic Dysfunction-Associated Steatotic Liver Disease
THE FUTURE of metabolic-dysfunction associated liver disease (MASLD) was discussed in an insightful session chaired by Hannes Hagström…
5
Mins
18 Jul 2024
Prevention of Decompensation in Compensated Cirrhosis
Portal hypertension is the major determinant of outcomes in patients with cirrhosis, defined as the presence of a hepatic venous pressure…
4
Mins
18 Jul 2024
Healthy Livers, Healthy Lives
NON-COMMUNICABLE diseases (NCD) represent a major global health challenge, with significant mortality and morbidity. Among these…
2
Mins
18 Jul 2024
Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Interruption in Hepatitis B Virus/HIV Co-Infected Individuals
Among hepatitis B virus (HBV) core antibody positive (cAb+) people with HIV, suppressive HBV treatment, including either tenofovir…
←
1
2
3
…
224
225
226
227
228
229
230
…
1,043
1,044
1,045
→